Skip to main content
more_vert
menu
chevron_left
home
Home
Our Mission
Our People
What We Do
For Students
Events
Outputs
News
Projects
Getting Involved
What We're Reading
May 05, 2020
With remdesivir, Gilead finds itself at strategic crossroads, with its reputation (and far more) at stake
Christopher Morten
Engelberg Center on Innovation Law & Policy
139 MacDougal Street Room 408, New York, NY 10012
engelberg.center@nyu.edu
@nyuengelberg.org
